Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

HER2 receptor tyrosine kinase inhibitors synthesized at Takeda

April 8, 1998

Zadaxin in combination with TACE shows promise in liver cancer therapy

April 8, 1998

Genta announces issue of patent for lead antisense compound

April 8, 1998

Orphan Medical announces results of Busulfex clinical trials

April 7, 1998

Novel apoptosis-related protease disclosed by Genetics Institute

April 7, 1998

More protein tyrosine kinase inhibitors in the pipeline at Glaxo Wellcome

April 7, 1998

New U.S. patent provides further protection for Onconase and related products

April 6, 1998

Protein tyrosine kinase inhibitors emerge from R&D at Glaxo Wellcome

April 6, 1998

TER-199 resistance-modulating mechanisms explored

April 6, 1998

CGP-60474: selective protein tyrosine kinase inhibitor for cancer

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...